Brokerages Set agilon health, inc. (NYSE:AGL) PT at $6.05

agilon health, inc. (NYSE:AGL) has received a consensus recommendation of “Reduce” from the twenty brokerages that are presently covering the company, MarketBeat reports. Three investment analysts have rated the stock with a sell recommendation, fifteen have given a hold recommendation and two have given a buy recommendation to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $6.05.

A number of brokerages have issued reports on AGL. William Blair lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday, November 8th. TD Cowen decreased their price target on shares of agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a research note on Monday, November 11th. JMP Securities downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday, November 11th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $3.00 price objective on shares of agilon health in a research report on Tuesday, November 19th. Finally, Citigroup dropped their target price on agilon health from $2.50 to $1.75 and set a “sell” rating on the stock in a report on Wednesday, November 13th.

agilon health Price Performance

Shares of AGL stock opened at $2.31 on Friday. The company has a market capitalization of $949.70 million, a PE ratio of -2.36 and a beta of 0.60. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The firm’s 50-day moving average is $2.73 and its two-hundred day moving average is $4.63. agilon health has a 12 month low of $1.50 and a 12 month high of $13.76.

agilon health (NYSE:AGL) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The company had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same quarter in the prior year, the business earned ($0.06) earnings per share. Analysts predict that agilon health will post -0.47 earnings per share for the current year.

Insider Buying and Selling at agilon health

In other agilon health news, CEO Steven Sell bought 20,000 shares of agilon health stock in a transaction dated Thursday, September 12th. The stock was acquired at an average cost of $3.36 per share, with a total value of $67,200.00. Following the completion of the acquisition, the chief executive officer now owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. This represents a 42.03 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 3.20% of the stock is owned by company insiders.

Hedge Funds Weigh In On agilon health

Institutional investors have recently added to or reduced their stakes in the stock. Virtu Financial LLC purchased a new position in shares of agilon health in the 3rd quarter valued at approximately $120,000. Geode Capital Management LLC grew its position in agilon health by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock valued at $27,097,000 after buying an additional 84,889 shares during the last quarter. Barclays PLC increased its stake in agilon health by 21.2% in the 3rd quarter. Barclays PLC now owns 1,228,952 shares of the company’s stock valued at $4,830,000 after buying an additional 214,830 shares during the period. XTX Topco Ltd raised its position in agilon health by 271.1% during the 3rd quarter. XTX Topco Ltd now owns 119,747 shares of the company’s stock worth $471,000 after buying an additional 87,481 shares during the last quarter. Finally, State Street Corp lifted its stake in shares of agilon health by 3.0% in the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company’s stock worth $29,277,000 after acquiring an additional 215,733 shares during the period.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.